Since the first quarter of 2015. Glenview has been steadily increasing its stake in HealthSouth, culminating with a 13G filing on July 31, showing a 5,903,100 share, or 6.5%, stake. The firm bought 1.7 million shares in Q1, 2.8 million in Q2 and 1.4 million shares between June 30 and July 21. As you can see, most of the shares (4.2 million) were bought between 04/01/15-07/21/15. The stock started this period of trading at $43.32 and ended at $45.77. Logic would suggest, Glenview's cost basis is in the low-to-mid range. With share trading at $42.10 currently, this gives you an...